| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.018 | 0.9 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.016 | 0.9 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |